Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Publications section now notes that entries are automatically filled from PubMed and the page revision updated to v3.3.2, replacing the previous wording about PubMed-derived publications and revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange Detected- The government funding lapse notice has been removed from the page. The clinical trial details and study information appear unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedEnrollment updated to 438 and the last update date shown as 2025-06-12. The locations section appears expanded to include additional sites across multiple countries.SummaryDifference0.2%

- Check62 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. If no other content changes are present, this indicates readiness/maintenance rather than new features.SummaryDifference2%

- Check69 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, signaling a software/version update with no substantive content changes.SummaryDifference0.0%

- Check84 days agoChange DetectedPage updated to v3.0.2 from v3.0.1; 'Back to Top' element removed.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.